Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Front Immunol ; 10: 109, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30863392

RESUMO

The receptor for advanced glycation end products (RAGE) interacts with various molecules in the cell membrane to induce an inflammatory response. The cytolethal distending toxin (CDT) produced by Campylobacter jejuni contains three subunits: CdtA, CdtB, and CdtC. Amongst, CdtA and CdtC interact with membrane lipid rafts, by which CdtB enters the nucleus to induce pathogenesis. In this study, we first explored the relationships between RAGE, lipid rafts, and inflammation in gastrointestinal epithelial cells exposed to CDT. Our results showed that CDT activated the expression of RAGE and high mobility group box 1 (HMGB1), followed by the recruitment of RAGE into lipid rafts. In contrast, RAGE antagonist inhibited CDT-induced inflammation via the RAGE-HMGB1 axis. Disruption of lipid rafts decreased CDT-induced downstream signaling, which in turn attenuated the inflammatory response. Furthermore, in vivo studies revealed severe inflammation and upregulation of RAGE and IL-1ß in the intestinal tissues of CDT-treated mice. These results demonstrate that mobilization of RAGE to lipid rafts plays a crucial role in CDT-induced inflammation.


Assuntos
Toxinas Bacterianas/metabolismo , Campylobacter jejuni/metabolismo , Inflamação/imunologia , Mucosa Intestinal/metabolismo , Microdomínios da Membrana/metabolismo , Receptor para Produtos Finais de Glicação Avançada/metabolismo , Animais , Células Cultivadas , Proteína HMGB1/genética , Proteína HMGB1/metabolismo , Interleucina-1beta/metabolismo , Mucosa Intestinal/patologia , Masculino , Microdomínios da Membrana/genética , Camundongos , Camundongos Endogâmicos BALB C , Transdução de Sinais , Regulação para Cima
2.
Artigo em Inglês | MEDLINE | ID: mdl-28642840

RESUMO

Cytolethal distending toxin (CDT) produced by Campylobacter jejuni contains three subunits: CdtA, CdtB, and CdtC. Among these three toxin subunits, CdtB is the toxic moiety of CDT with DNase I activity, resulting in DNA double-strand breaks (DSB) and, consequently, cell cycle arrest at the G2/M stage and apoptosis. Radiation therapy is an effective modality for the treatment of localized prostate cancer (PCa). However, patients often develop radioresistance. Owing to its particular biochemical properties, we previously employed CdtB as a therapeutic agent for sensitizing radioresistant PCa cells to ionizing radiation (IR). In this study, we further demonstrated that CDT suppresses the IR-induced autophagy pathway in PCa cells by attenuating c-Myc expression and therefore sensitizes PCa cells to radiation. We further showed that CDT prevents the formation of autophagosomes via decreased high-mobility group box 1 (HMGB1) expression and the inhibition of acidic vesicular organelle (AVO) formation, which are associated with enhanced radiosensitivity in PCa cells. The results of this study reveal the detailed mechanism of CDT for the treatment of radioresistant PCa.


Assuntos
Toxinas Bacterianas/farmacologia , Próstata/efeitos dos fármacos , Próstata/efeitos da radiação , Neoplasias da Próstata/tratamento farmacológico , Neoplasias da Próstata/radioterapia , Tolerância a Radiação/efeitos dos fármacos , Animais , Apoptose/efeitos dos fármacos , Apoptose/efeitos da radiação , Autofagossomos/efeitos dos fármacos , Autofagia/efeitos dos fármacos , Autofagia/efeitos da radiação , Campylobacter jejuni/metabolismo , Ciclo Celular/efeitos dos fármacos , Pontos de Checagem do Ciclo Celular/efeitos dos fármacos , Linhagem Celular , Quimioterapia Combinada , Proteína HMGB1/efeitos dos fármacos , Proteína HMGB1/metabolismo , Humanos , Masculino , Camundongos
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa